[Priority of using conventional cytogenetics, in situ hybridization and PCR in the study of hematologic neoplasms].
Solé
F
F
Espinet
B
B
Woessner
S
S
D015139:Blotting, Southern; D002869:Chromosome Aberrations; D019337:Hematologic Neoplasms / Q000235:genetics* / Q000473:pathology; D006801:Humans; D017403:In Situ Hybridization; D007621:Karyotyping; D016133:Polymerase Chain Reaction
Prioridad de utilización de la citogenética convencional, hibridación in situ, y PCR en el estudio de las neoplasias hematológicas.